GR3031850T3 - Peptides with insulin like activity. - Google Patents
Peptides with insulin like activity.Info
- Publication number
- GR3031850T3 GR3031850T3 GR990402944T GR990402944T GR3031850T3 GR 3031850 T3 GR3031850 T3 GR 3031850T3 GR 990402944 T GR990402944 T GR 990402944T GR 990402944 T GR990402944 T GR 990402944T GR 3031850 T3 GR3031850 T3 GR 3031850T3
- Authority
- GR
- Greece
- Prior art keywords
- residue
- insulin
- acid residue
- alkyl
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4139376 | 1991-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3031850T3 true GR3031850T3 (en) | 2000-02-29 |
Family
ID=6445910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR990402944T GR3031850T3 (en) | 1991-11-29 | 1999-11-17 | Peptides with insulin like activity. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5622934A (el) |
EP (1) | EP0545198B1 (el) |
JP (1) | JP3324804B2 (el) |
AT (1) | ATE184611T1 (el) |
DE (1) | DE59209745D1 (el) |
DK (1) | DK0545198T3 (el) |
ES (1) | ES2137937T3 (el) |
FI (1) | FI925370A (el) |
GR (1) | GR3031850T3 (el) |
NO (1) | NO309146B1 (el) |
SG (1) | SG46640A1 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
US5948751A (en) * | 1996-06-20 | 1999-09-07 | Novo Nordisk A/S | X14-mannitol |
KR100481746B1 (ko) * | 1996-11-28 | 2005-08-10 | 훽스트 악티엔게젤샤프트 | 인슐린-유사작용을갖는이노시톨글리칸및이를포함하는약제학적제제 |
DE19649350A1 (de) * | 1996-11-28 | 1998-06-04 | Hoechst Ag | Inositolglykane mit insulinartiger Wirkung |
US20070010573A1 (en) * | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
WO2006085149A2 (en) | 2004-12-22 | 2006-08-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
DK2089417T3 (en) * | 2006-10-12 | 2015-03-23 | Bhi Ltd Partnership | Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2801175A1 (de) * | 1978-01-12 | 1979-07-19 | Hoechst Ag | Verfahren zur herstellung cysteinhaltiger peptide |
DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
US4515920A (en) * | 1984-04-30 | 1985-05-07 | The Rockefeller University | Synthesis of peptides and proteins |
AU605214B2 (en) * | 1986-10-24 | 1991-01-10 | Fresenius Kabi Ab | N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration |
EP0288897B1 (de) * | 1987-04-25 | 1993-08-11 | Hoechst Aktiengesellschaft | Enkastine: Neue Glycopeptide mit Enkephalinase-hemmender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutische Präparate |
NZ232562A (en) * | 1989-02-17 | 1992-10-28 | Coselco Mimotopes Pty Ltd | Immobilised peptide - solid support comprising a cleavable ester link between the peptide carboxy terminus and the solid support |
AU6733190A (en) * | 1989-11-27 | 1991-06-26 | Santen Pharmaceutical Co. Ltd. | Amino acid derivative |
TW227004B (el) * | 1990-12-19 | 1994-07-21 | Hoechst Ag | |
YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
-
1992
- 1992-11-23 AT AT92119913T patent/ATE184611T1/de active
- 1992-11-23 EP EP92119913A patent/EP0545198B1/de not_active Expired - Lifetime
- 1992-11-23 ES ES92119913T patent/ES2137937T3/es not_active Expired - Lifetime
- 1992-11-23 SG SG1996006947A patent/SG46640A1/en unknown
- 1992-11-23 DE DE59209745T patent/DE59209745D1/de not_active Expired - Lifetime
- 1992-11-23 DK DK92119913T patent/DK0545198T3/da active
- 1992-11-26 FI FI925370A patent/FI925370A/fi unknown
- 1992-11-27 JP JP31878392A patent/JP3324804B2/ja not_active Expired - Lifetime
- 1992-11-27 NO NO924585A patent/NO309146B1/no not_active IP Right Cessation
-
1994
- 1994-05-23 US US08/247,394 patent/US5622934A/en not_active Expired - Lifetime
-
1999
- 1999-11-17 GR GR990402944T patent/GR3031850T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05247088A (ja) | 1993-09-24 |
DE59209745D1 (de) | 1999-10-21 |
FI925370A0 (fi) | 1992-11-26 |
DK0545198T3 (da) | 2000-03-20 |
FI925370A (fi) | 1993-05-30 |
EP0545198A2 (de) | 1993-06-09 |
NO924585D0 (no) | 1992-11-27 |
EP0545198B1 (de) | 1999-09-15 |
ES2137937T3 (es) | 2000-01-01 |
EP0545198A3 (el) | 1994-03-23 |
JP3324804B2 (ja) | 2002-09-17 |
US5622934A (en) | 1997-04-22 |
SG46640A1 (en) | 1998-02-20 |
NO924585L (no) | 1993-06-01 |
NO309146B1 (no) | 2000-12-18 |
ATE184611T1 (de) | 1999-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2018635A6 (es) | Procedimiento de obtencion de adhesivos polisonizados metabolicamente aceptables. | |
AU564648B2 (en) | Insulin agent | |
AU1022892A (en) | Dental/medical composition and use | |
ES8504678A1 (es) | Procedimiento para la preparacion de un derivado de insulina | |
GR3019361T3 (en) | Use of halogenated hydrocarbon solvents as cleaning agents | |
ATE196298T1 (de) | Oberflächenaktives lungenprotein und verwandte polypeptide | |
MY102585A (en) | N-cyanoisothioureas and use thereof in pest control | |
EP0479210A3 (en) | Gip analogues and use thereof | |
GR3031850T3 (en) | Peptides with insulin like activity. | |
CA2004991A1 (en) | Deletion analogues of magainin peptides | |
IL89128A0 (en) | Diacylation of compounds containing two aromatic rings | |
EP0968721A3 (en) | Use of a composition comprising a peptide for the inhibition of HIV | |
NZ241029A (en) | Peptides with cysteine residue or dimers thereof with insulin activity and pharmaceutical compositions | |
ZA89431B (en) | Oxadiazole compounds,their preparation and their use as pesticides | |
AU2063388A (en) | Preparation for preventing or combating complications in diabetes | |
IL111361A0 (en) | Pharmaceutical compositions for the treatment of insulin dependent diabetes mellitus (iddm) | |
ATE87939T1 (de) | Glycosylierte aminosaeuren und peptide. | |
ATE102953T1 (de) | Retro-inverso-thrymopentin-analoge, verfahren zu deren herstellung und deren verwendung fuer die zubereitung von pharmazeutischen zusammensetzungen. |